Various studies suggested serum irisin levels were decreased in patients with CAD, indicating the positive effects of irisin on CAD (Khorasani et al., 2019; Wang S. et al., 2019; Guo et al., 2020). Here, FNDC5 is linked to coronary artery disorder.